Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01689584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COsegregation of VARiants in Panel of Genes

Study acronym: COVAR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 2 of 62 sitesv14
  2. Enrollment target: 3500 to 11000v13 Show 8 more changesShow less
    • Primary completion date: Jan 2, 2033 to Jul 2, 2037
    • Primary endpoint revised
    • Study sites: 57 to 62
    • Study completion date: Jan 2, 2034 to Jan 2, 2038
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 16 words
    • Publications expanded, about 1,441 words
  3. Re-verified, no change to tracked fieldsv12
  4. Primary completion date: Oct 2023 to Jan 2, 2033
    • Start date: Apr 2012 to Jul 2, 2012
    • Study completion date: Oct 2028 to Jan 2, 2034
    • Site details revised at 11 of 57 sites
    v11
  5. Primary completion date: Dec 2022 to Oct 2023
    • Study completion date: Dec 2027 to Oct 2028
    • Site contacts updated at 3 of 57 sites
    v10
Show 8 earlier versionsHide 8 earlier versions
  1. Enrollment target: 2000 to 3500v9 Show 4 more changesShow less
    • Study sites: 58 to 57
    • Eligibility criteria shortened, about 6 words
    • Study description shortened, about 43 words
    • Study title shortened, about 2 words
  2. Re-verified, no change to tracked fieldsv8
  3. Study sites: 57 to 58v7
  4. Re-verified, no change to tracked fieldsv6
  5. Study sites: 52 to 57
    • Study description expanded, about 139 words
    • Eligibility criteria expanded, about 2 words
    • Study title expanded, about 2 words
    v5
  6. Re-verified, no change to tracked fieldsv4
  7. Study sites: 45 to 52v3
  8. Study sites: 2 to 45v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Curie
43 trials monitored
See 1 trial at risk
The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, https://frog-db.fr/) in order to use them for the genetic counseling. The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.
Trial Details
NCT Number NCT01689584
Lead Sponsor Institut Curie
Conditions
(from sponsor)		 Gene Mutation-Related Cancer, Genetic Predisposition
Related terms Genetic Predisposition to Disease
Enrollment 11,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov